• Profile

A randomized controlled trial evaluating sildenafil citrate in relieving ureteral stent-related symptoms

World Journal of Urology May 19, 2018

Tharwat M, et al. - Researchers assessed the role of sildenafil in relieving ureteral stent symptoms. They conducted a randomized controlled trial between March 2014 and November 2016 including adult men who underwent unilateral ureteric stent after ureteroscopy. Using sealed closed envelope, eligible patients were randomized to one of 2 groups (S and C). Significantly lower total ureteral stent symptom questionnaire (USSQ) score and all domains (except work performance) was seen in group S. In group C, dysuria and urgency were significantly more. Sildenafil is an effective and well-tolerated treatment option for relieving ureteral stent-related symptoms in men.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen